mRNAs containing the histone 3′ stem-loop are degraded primarily by decapping mediated by oligouridylation of the 3′ end

RNA

Volumn 19, Issue 1, 2013, Pages 1-16

  Su, Wei ^a   Slepenkov, Sergey V ^a   Slevin, Michael K ^b   Lyons, Shawn M ^b   Ziemniak, Marcin ^c   Kowalska, Joanna ^c   Darzynkiewicz, Edward ^c   Jemielity, Jacek ^c   Marzluff, William F ^b   Rhoads, Robert E ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cordycepin; hDcp2 resistant cap analog; Hydroxyurea; Oligouridylation; TUTase 4

Indexed keywords

CORDYCEPIN; FIREFLY LUCIFERASE; HEXOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; HISTONE H3; HYDROXYUREA; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; DNA REPLICATION; DNA SYNTHESIS; GENE SILENCING; HUMAN; PRIORITY JOURNAL; RNA DEGRADATION;

3' UNTRANSLATED REGIONS; DEOXYADENOSINES; DNA REPLICATION; GENE SILENCING; HELA CELLS; HISTONES; HUMANS; HYDROXYUREA; NUCLEIC ACID SYNTHESIS INHIBITORS; OLIGORIBONUCLEOTIDES; POLYNUCLEOTIDE ADENYLYLTRANSFERASE; PROTEIN BIOSYNTHESIS; RNA STABILITY; RNA, MESSENGER; TRANSDUCTION, GENETIC; URACIL NUCLEOTIDES;

METAZOA;

EID: 84871455409     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.034470.112     Document Type: Article

References (59)

1. Charlesworth A, Cox LL, MacNicol AM. 2004. Cytoplasmic polyadenylation element (CPE)- and CPE-binding protein (CPEB)-independent mechanisms regulate early class maternal mRNA translational activation in Xenopus oocytes. J Biol Chem 279: 17650-17659.
2. Chen CY, Shyu AB. 1995. AU-rich elements: Characterization and importance in mRNA degradation. Trends Biochem Sci 20: 465-470.
3. Chen CY, Shyu AB. 2011. Mechanisms of deadenylation-dependent decay. Wiley Interdiscip Rev RNA 2: 167-183.
4. Chen CY, Xu N, Shyu AB. 1995. mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: Different deadenylation kinetics and uncoupling from translation. Mol Cell Biol 15: 5777-5788.
5. Coller J, Parker R. 2004. Eukaryotic mRNA decapping. Annu Rev Biochem 73: 861-890.
6. Coller J, Parker R. 2005. General translational repression by activators of mRNA decapping. Cell 122: 875-886.
7. Curatola AM, Nadal MS, Schneider RJ. 1995. Rapid degradation of AU-rich element (ARE) mRNAs is activated by ribosome transit and blocked by secondary structure at any position 5′ to the ARE. Mol Cell Biol 15: 6331-6340.
8. Diken M, Kreiter S, Selmi A, Britten C, Huber C, Tureci Ö, Sahin U. 2011. Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation. Gene Ther 18: 702-708.
9. Gallie DR, Lewis NJ, Marzluff WF. 1996. The histone 3′-terminal stem-loop is necessary for translation in Chinese hamster ovary cells. Nucleic Acids Res 24: 1954-1962.
10. Graves RA, Pandey NB, Chodchoy N, Marzluff WF. 1987. Translation is required for regulation of histone mRNA degradation. Cell 48: 615-626.
11. Grudzien E, Kalek M, Jemielity J, Darzynkiewicz E, Rhoads RE. 2006. Differential inhibition of mRNA degradation pathways by novel cap analogs. J Biol Chem 281: 1857-1867.
12. Grudzien-Nogalska E, Jemielity J, Kowalska J, Darzynkiewicz E, Rhoads RE. 2007a. Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells. RNA 13: 1745-1755.
13. Grudzien-Nogalska E, Stepinski J, Jemielity J, Zuberek J, Stolarski R, Rhoads RE, Darzynkiewicz E. 2007b. Synthesis of anti-reverse cap analogs (ARCAs) and their applications in mRNA translation and stability. Methods Enzymol 431: 203-227.
14. Guyette WA, Matusik RJ, Rosen JM. 1979. Prolactin-mediated transcriptional and post-transcriptional control of casein gene expression. Cell 17: 1013-1023.
15. Harris ME, Bohni R, Schneiderman MH, Ramamurthy L, Schumperli D, Marzluff WF. 1991. Regulation of histone mRNA in the unperturbed cell cycle: Evidence suggesting control at two post-transcriptional steps. Mol Cell Biol 11: 2416-2424.
16. Henikoff S, Ahmad K. 2005. Assembly of variant histones into chromatin. Annu Rev Cell Dev Biol 21: 133-153.
17. Horowitz B, Goldfinger B, Marmur J. 1976. Effect of cordycepin triphosphate on the nuclear DNA-dependent RNA polymerases and poly(A) polymerase from the yeast Saccharomyces cerevisiae. Arch Biochem Biophys 172: 143-148.
18. Jackman J, O'Connor PM. 2001. Methods for synchronizing cells at specific stages of the cell cycle. In Current protocols in cell biology. J. Wiley, Hoboken, NJ. doi: 10.1002/0471143030.cb0803s00.
19. Jemielity J, Fowler T, Zuberek J, Stepinski J, Lewdorowicz M, Niedzwiecka A, Stolarski R, Darzynkiewicz E, Rhoads RE. 2003. Novel "anti- reverse" cap analogues with superior translational properties. RNA 9: 1108-1122.
20. Jiao X, Xiang S, Oh C, Martin C, Tong L, Kiledjian M. 2010. Identification of a quality-control mechanism for mRNA 5′-end capping. Nature 467: 608-611.
21. Kaygun H, Marzluff WF. 2005. Regulated degradation of replication-dependent histone mRNAs requires both ATR and Upf1. Nat Struct Mol Biol 12: 794-800.
22. Kingston RE, Chen CA, Rose JK. 2003. Calcium phosphate transfection. In Current protocols in molecular biology, pp 9.1.1-9.1.11. J. Wiley, Hoboken, NJ.
23. Kitamura T, Ogawa W, Sakaue H, Hino Y, Kuroda S, Takata M, Matsumoto M, Maeda T, Konishi H, Kikkawa U, et al. 1998. Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Mol Cell Biol 18: 3708-3717.
24. Kowalska J, Lewdorowicz M, Zuberek J, Grudzien-Nogalska E, Bojarska E, Stepinski J, Rhoads RE, Darzynkiewicz E, Davis RE, Jemielity J. 2008. Synthesis and characterization of mRNA cap analogs containing phosphorothioate substitutions that bind tightly to eIF4E and are resistant to the decapping pyrophosphatase DcpS. RNA 14: 1119-1131.
25. Kuhn AN, Diken M, Kreiter S, Selmi A, Kowalska J, Jemielity J, Darzynkiewicz E, Huber C, Tureci O, Sahin U. 2010. Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo. Gene Ther 17: 961-971.
26. Kuhn AN, Diken M, Kreiter S, Vallazza B, Tureci Ö, Sahin U. 2011. Determinants of intracellular RNA pharmacokinetics: Implications for RNA-based immunotherapeutics. RNA Biol 8: 35-43.
27. Kurosawa A, Saito S, Mori M, Adachi N. 2012. Nucleofection-based gene targeting in human pre-B cells. Gene 492: 305-308.
28. Ling J, Morley SJ, Pain VM, Marzluff WF, Gallie DR. 2002. The Histone 3′-terminal stem-loop-binding protein enhances translation through a functional and physical interaction with eukaryotic initiation factor 4G (eIF4G) and eIF3. Mol Cell Biol 22: 7853-7867.
29. Lu G, Zhang J, Li Y, Li Z, Zhang N, Xu X, Wang T, Guan Z, Gao GF, Yan J. 2011. hNUDT16: A universal decapping enzyme for small nucleolar RNA and cytoplasmic mRNA. Protein Cell 2: 64-73.
30. Martinet W, Schrijvers DM, Kockx MM. 2003. Nucleofection as an efficient nonviral transfection method for human monocytic cells. Biotechnol Lett 25: 1025-1029.
31. Marzluff WF, Wagner EJ, Duronio RJ. 2008. Metabolism and regulation of canonical histone mRNAs: Life without a poly(A) tail. Nat Rev Genet 9: 843-854.
32. Milligan J, Groebe D, Witherell G, Uhlenbeck O. 1987. Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res 15: 8783-8798.
33. Muhlrad D, Decker C, Parker R. 1994. Deadenylation of the unstable mRNA encoded by the yeast MFA2 gene leads to decapping followed by 5′ → 3′ digestion of the transcript. Genes Dev 8: 855-866.
34. Mukherjee D, Gao M, O'Connor JP, Raijmakers R, Pruijn G, Lutz CS, Wilusz J. 2002. The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements. EMBO J 21: 165-174.
35. Mullen TE, Marzluff WF. 2008. Degradation of histone mRNA requires oligouridylation followed by decapping and simultaneous degradation of the mRNA both 5′ to 3′ and 3′ to 5′. Genes Dev 22: 50-65.
36. Muller WEG, Seibert G, Beyer R, Breter HJ, Maidhof A, Zahn RK. 1977. Effect of cordycepin on nucleic acid metabolism in L5178Y cells and on nucleic acid-synthesizing enzyme systems. Cancer Res 37: 3824-3833.
37. Niepel M, Ling J, Gallie D. 1999. Secondary structure in the 5′-leader or 3′-untranslated region reduces protein yield but does not affect the functional interaction between the 5′-cap and the poly(A) tail. FEBS Lett 462: 79-84.
38. Palmiter RD, Carey NH. 1974. Rapid inactivation of ovalbumin messenger ribonucleic acid after acute withdrawal of estrogen. Proc Natl Acad Sci 71: 2357-2361.
39. Pandey NB, Marzluff WF. 1987. The stem-loop structure at the 3′ end of histone mRNA is necessary and sufficient for regulation of histone mRNA stability. Mol Cell Biol 7: 4557-4559.
40. Parker R, Sheth U. 2007. P bodies and the control of mRNA translation and degradation. Mol Cell 25: 635-646.
41. Rissland OS, Norbury CJ. 2008. The Cid1 poly(U) polymerase. Biochim Biophys Acta 1779: 286-294.
42. Rissland OS, Norbury CJ. 2009. Decapping is preceded by 3′ uridylation in a novel pathway of bulk mRNA turnover. Nat Struct Mol Biol 16: 616-623.
43. Ross J, Peltz SW, Kobs G, Brewer G. 1986. Histone mRNA degradation in vivo: The first detectable step occurs at or near the 3′ terminus. Mol Cell Biol 6: 4362-4371.
44. Ross J, Kobs G, Brewer G, Peltz SW. 1987. Properties of the exonuclease activity that degrades H4 histone mRNA. J Biol Chem 262: 9374-9381.
45. Russell JE, Liebhaber SA. 1996. The stability of human β-globin mRNA is dependent on structural determinants positioned within its 3′ untranslated region. Blood 87: 5314-5323.
46. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: A laboratory manual . Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
47. Sanchez R, Marzluff WF. 2002. The stem-loop binding protein is required for efficient translation of histone mRNA in vivo and in vitro. Mol Cell Biol 22: 7093-7104.
48. Schmidt M-J, West S, Norbury CJ. 2011. The human cytoplasmic RNA terminal U-transferase ZCCHC11 targets histone mRNAs for degradation. RNA 17: 39-44.
49. Schoenberg DR. 2011. Mechanisms of endonuclease-mediated mRNA decay. Wiley Interdiscip Rev RNA 2: 582-600.
50. Shaw G, Kamen R. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659-667.
51. Sittman DB, Graves RA, Marzluff WF. 1983. Histone mRNA concentrations are regulated at the level of transcription and mRNA degradation. Proc Natl Acad Sci 80: 1849-1853.
52. Song M-G, Kiledjian M. 2007. 3′ Terminal oligo U-tract-mediated stimulation of decapping. RNA 13: 2356-2365.
53. Stepinski J, Waddell C, Stolarski R, Darzynkiewicz E, Rhoads RE. 2001. Synthesis and properties of mRNAs containing the novel "anti-reverse" cap analogues 7-methyl(3′-O-methyl)GpppG and 7-methyl(3′-deoxy) GpppG. RNA 7: 1486-1495.
54. Su W, Slepenkov S, Grudzien-Nogalska E, Kowalska J, Kulis M, Zuberek J, Lukaszewicz M, Darzynkiewicz E, Jemielity J, Rhoads RE. 2011. Translation, stability, and resistance to decapping of mRNAs containing caps substituted in the triphosphate chain with BH3, Se, and NH. RNA 17: 978-988.
55. Weide B, Garbe C, Rammensee HG, Pascolo S. 2008. Plasmid DNA- and messenger RNA-based anti-cancer vaccination. Immunol Lett 115: 33-42.
56. Whitfield ML, Zheng L-X, Baldwin A, Ohta T, Hurt MM, Marzluff WF. 2000. Stem-loop binding protein, the protein that binds the 3′ end of histone mRNA, is cell cycle regulated by both translational and posttranslational mechanisms. Mol Cell Biol 20: 4188-4198.
57. Williams AS, Ingledue TC, Kay BK, Marzluff WF. 1994. Changes in the stem-loop at the 3′ terminus of histone mRNA affects its nucleocytoplasmic transport and cytoplasmic regulation. Nucleic Acids Res 22: 4660-4666.
58. Xiang S, Cooper-Morgan A, Jiao X, Kiledjian M, Manley JL, Tong L. 2009. Structure and function of the 5′-3′ exoribonuclease Rat1 and its activating partner Rai1. Nature 458: 784-788.
59. Ye X, Franco AA, Santos H, Nelson DM, Kaufman PD, Adams PD. 2003. Defective S phase chromatin assembly causes DNA damage, activation of the S phase checkpoint, and S phase arrest. Mol Cell 11: 341-351.